NEW YORK–(BUSINESS WIRE)–Edgemont Partners (“Edgemont”), a outstanding middle-market healthcare funding financial institution and a number one M&A advisor to pharmaceutical companies and eClinical know-how corporations, introduced that it acted as unique monetary advisor to ActiGraph in its transaction with ArchiMed. The phrases of the transaction, which closed on Might 7, 2020, weren’t disclosed. Edgemont’s deal staff included David Blume, Managing Director, Patrick Bradley, Director, Daniel Smallegan, Affiliate, and Michael Veverka, Analyst.
ActiGraph is a number one supplier of medical-grade bodily exercise and sleep monitoring options for the worldwide scientific neighborhood. The Firm’s know-how and information options have pioneered distant affected person information assortment and options for biotech and pharmaceutical corporations and the tutorial analysis marketplace for over 20 years. Use of digital biomarkers are quickly rising in drug growth and ActiGraph’s options are ideally suited to assist this pattern.
The sale of ActiGraph is Edgemont’s 20th pharmaceutical companies and know-how transaction closed up to now 30 months. Different latest transactions embody the sale of Analysis Facilities of America to Cenexel, Pharmerit’s merger with OPEN Well being, the sale of J. Knipper to Court docket Sq. Capital Companions and the sale of GCE Options to a number one world CRO.
ActiGraph’s mission is to assist individuals dwell longer, higher lives. ActiGraph does that by offering shoppers with excessive decision, digital information that can be utilized to clarify, affect, and predict human well being outcomes. ActiGraph is a number one supplier of medical-grade bodily exercise and sleep monitoring options for the worldwide scientific neighborhood. ActiGraph’s FDA-cleared wearable exercise screens and sturdy information administration and analytics platform have been used extensively to quantify human motion in tutorial and inhabitants well being analysis for 20 years. Extra not too long ago, ActiGraph know-how options have been broadly adopted by pharmaceutical and life sciences organizations looking for to seize and monitor real-world bodily exercise, mobility, and sleep habits for sufferers enrolled in medical trials. For extra data go to: www.actigraphcorp.com
ArchiMed is an unbiased funding agency specialised within the Healthcare industries. It’s a strategic and monetary associate to European and North American corporations working within the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Client Well being, Public Security and Care Providers sectors. ArchiMed’s worldwide staff combines funding, medical, technological and operational expertise. It really works alongside administration groups to speed up their enterprise progress, via internationalization, product and repair vary enlargement in addition to capability extension, each organically and thru acquisitions. Over the past 20 years, ArchiMed’s management staff instantly managed and invested in over 40 small, medium and large-size healthcare corporations all through the world, with a mixed worth above 5 billion euros. ArchiMed’s funding capability presently exceeds one billion euros and doubtlessly twice this quantity when together with its strategic funding companions. For extra data go to: www.archimed-group.eu
About Edgemont Companions
Edgemont Companions is among the nation’s premier healthcare funding banks, offering merger and acquisition advisory and capital elevating companies solely for healthcare corporations. We focus solely on offering knowledgeable strategic recommendation and transaction execution, bringing a steadfast dedication to our shoppers, pushed at all times by what’s in the most effective curiosity of our shoppers. In our 19-year historical past, Edgemont has executed 155+ transactions with an combination worth of 62 B+.
Funding banking companies are supplied by Edgemont Capital Companions, LP, a registered broker-dealer and member of FINRA and SIPC.